Table 1 The relationship between preoperative clinical data and EOR
Factors | Total | % | SMR | % | TR | % | P value | |
|---|---|---|---|---|---|---|---|---|
Total | 106 | Â | 41 | 38.7% | 65 | 61.3% | Â | |
Gender | Male | 59 | 55.7% | 25 | 42.4% | 34 | 57.6% | 0.382 |
Female | 47 | 44.3% | 16 | 34.0% | 31 | 66.0% | ||
Age group | 18–47 | 40 | 37.7% | 20 | 50.0% | 20 | 50.0% | 0.134 |
48–63 | 51 | 48.1% | 15 | 29.4% | 36 | 70.6% | ||
63–75 | 15 | 14.2% | 6 | 40.0% | 9 | 60.0% | ||
Tumor location | Anterior (Rostrum+Genu) | 57 | 53.8% | 24 | 42.1% | 33 | 57.9% | 0.544 |
Posterior (Isthmus+Spleniu) | 24 | 22.6% | 7 | 29.2% | 17 | 70.8% | ||
Body | 25 | 23.6% | 10 | 40.0% | 15 | 60.0% | ||
Tumor volume (cm3) | Mean + SD | 55.2 ± 16.6 |  | 54.0 ± 16.9 |  | 56.0 ± 16.5 |  | 0.566 |
Pathology | Astrocytoma, WHO 4, IDH mutation | 31 | 29.2% | 14 | 45.2% | 17 | 54.8% | 0.378 |
Glioblastoma | 75 | 70.8% | 27 | 36.0% | 48 | 64.0% | ||
KPS | ≥70 | 70 | 66.0% | 27 | 38.6% | 43 | 61.4% | 0.975 |
< 70 | 36 | 34.0% | 14 | 38.9% | 22 | 61.1% | ||
NIHSS | 0 | 36 | 34.0% | 18 | 50.0% | 18 | 50.0% | 0.190 |
1–4 | 52 | 49.1% | 16 | 30.8% | 36 | 69.2% | ||
> 4 | 18 | 17.0% | 7 | 38.9% | 11 | 61.1% | ||
Dyskinesia | Positive | 45 | 42.5% | 12 | 26.7% | 33 | 73.3% | 0.029 |
Negative | 61 | 57.5% | 29 | 47.5% | 32 | 52.5% | ||
Hypoesthesia | Positive | 25 | 23.6% | 6 | 24.0% | 19 | 76.0% | 0.085 |
Negative | 81 | 76.4% | 35 | 43.2% | 46 | 56.8% | ||
Aphasia | Positive | 21 | 19.8% | 8 | 38.1% | 13 | 61.9% | 0.951 |
Negative | 85 | 80.2% | 33 | 38.8% | 52 | 61.2% | ||
Cognitive deficit | Positive | 37 | 34.9% | 14 | 37.8% | 23 | 62.2% | 0.896 |
Negative | 69 | 65.1% | 27 | 39.1% | 42 | 60.9% | ||